Home
Current Clinical Trials
Learn More
Non-viral precision T cell receptor replacement for personalized cell therapy
Read Here
New Infusion Center
Read More
About
UCI Alpha Clinic provides a centralized infrastructure to enhance cell and gene therapy clinical research and activities at UCI. The UCI Alpha Clinic:
- Is part of California Institute for Regenerative Medicine (CIRM).
- Promotes and facilitates scientific collaborations and interactions.
- Provides centralized clinical research infrastructure support.
- Accelerates the implementation of clinical research trials.
Stem-cell therapy for Parkinson’s disease shows promise in early study
Study of dopamine-producing neural cells raises hope for patients, UCI Health expert says.
Clinical trial targets antibodies to treat rare form of myasthenia gravis
“We are in the early stages, but our hope is to bring about improvement while limiting side effects and perhaps one day gain the ability to eliminate the disease,” says neurologist Dr. Ali Habib of a first-in-human clinical trial at the UCI Alpha Clinic for a rare form of myasthenia gravis.
UCI tests cell therapy for myasthenia gravis
UCI Health and the UCI Alpha Clinic are conducting a clinical trial of an investigational cell therapy in patients with generalized myasthenia gravis, a rare autoimmune disorder.
Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy
- Date: September 20, 2024
- Time: 11:00 AM - 4:30 PM ET
- Location: This is a virtual public listening meeting and will be held via Zoom.
- Registration: Register here
UCI Alpha Clinic
Gross Hall: A CIRM Institute
University of California, Irvine
845 Health Sciences Road
1001 Gross Hall
Irvine, CA 92697-1705
Phone: (949) 824-3990
Email: alphaclinic@uci.edu